COUP-TFII switches responses of venous endothelium to atherosclerotic factors through controlling the profile of various inherent genes expression

Journal of Cellular Biochemistry

Volumn 112, Issue 1, 2011, Pages 256-264

  Wu, Xiaojing ^a,b   Zou, Yunzeng ^a   Liang, Yanyan ^a   Zhou, Qi ^c   Gong, Hui ^a   Sun, Aijun ^a   Yuan, Lingyan ^a   Wang, Keqiang ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Artery; Atherosclerosis; Endothelial cell; Gene; Vein

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHEMOKINE RECEPTOR CCR1; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; JAGGED1; LIPOPROTEIN A; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; NOTCH1 RECEPTOR; RANTES; STROMELYSIN; VON WILLEBRAND FACTOR;

ADULT; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CAVA VEIN; CELL ADHESION; CLINICAL ASSESSMENT; DNA MICROARRAY; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME INDUCTION; GENE EXPRESSION; HUMAN; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VEIN ENDOTHELIUM;

ANIMALS; CALCIUM-BINDING PROTEINS; COUP TRANSCRIPTION FACTOR II; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; PLAQUE, ATHEROSCLEROTIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, NOTCH1; VEINS;

EID: 78651327729     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22923     Document Type: Article

References (35)

1. Aird WC. 2006. Mechanisms of endothelial cell heterogeneity in health and disease. Circ Res 98:159-162.
2. Aird WC. 2006. Endothelial cell heterogeneity and atherosclerosis. Curr Atheroscler Rep 8:69-75.
3. Aird WC. 2007. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 100:174-190.
4. Amberger A, Maczek C, Jurgens G, Michaelis D, Schett G, Trieb K, Eberl T, Jindal S, Xu Q, Wick G. 1997. Co-expression of ICAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipoproteins. Cell Stress Chaperones 2: 94-103.
5. Bardoux P, Zhang P, Flamez D, Perilhou A, Lavin TA, Tanti JF, Hellemans K, Gomas E, Godard C, Andreelli F, Buccheri MA, Kahn A, Le Marchand-Brustel Y, Burcelin R, Schuit F, Vasseur-Cognet M. 2005. Essential role of chicken ovalbumin upstream promoter-transcription factor II in insulin secretion and insulin sensitivity revealed by conditional gene knockout. Diabetes 54:1357-1363.
6. Barter PJ, Rye KA. 2006. The rationale for using apoA-I as a clinical marker of cardiovascular risk. J Intern Med 259:447-454.
7. Blann AD. 2006. Plasma von Willebrand factor, thrombosis, and the endothelium: The first 30 years. Thromb Haemost 95:49-55.
8. Boisvert WA. 2004. Modulation of atherogenesis by chemokines. Trends Cardiovasc Med 14:161-165.
9. Buholzer CF, Arrighi JF, Abraham S, Piguet V, Capponi AM, Casal AJ. 2005. Chicken ovalbumin upstream promoter-transcription factor is a negative regulator of steroidogenesis in bovine adrenal glomerulosa cells. Mol Endocrinol 19:65-75.
10. Catena C, Novello M, Lapenna R, Baroselli S, Colussi G, Nadalini E, Favret G, Cavarape A, Soardo G, Sechi LA. 2005. New risk factors for atherosclerosis in hypertension: Focus on the prothrombotic state and lipoprotein(a). J Hypertens 23:1617-1631.
11. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. 2007. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: Molecular, cellular, and vascular behavior. J Am Coll Cardiol 49:2379-2393.
12. Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z, Rockson SG, van de Rijn M, Botstein D, Brown PO. 2003. Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci USA 100:10623-10628.
13. Curtiss LK, Boisvert WA. 2000. Apolipoprotein E and atherosclerosis. Curr Opin Lipidol 11:243-251.
14. De Martino MU, Alesci S, Chrousos GP, Kino T. 2004. Interaction of the glucocorticoid receptor and the chicken ovalbumin upstream promotertranscription factor II (COUP-TFII): Implications for the actions of glucocorticoids on glucose, lipoprotein, and xenobiotic metabolism. Ann NY Acad Sci 1024:72-85.
15. Deng DX, Tsalenko A, Vailaya A, Ben-Dor A, Kundu R, Estay I, Tabibiazar R, Kincaid R, Yakhini Z, Bruhn L, Quertermous T. 2006. Differences in vascular bed disease susceptibility reflect differences in gene expression response to atherogenic stimuli. Circ Res 98:200-208.
16. Gerritsen ME. 1987. Functional heterogeneity of vascular endothelial cells. Biochem Pharmacol 36:2701-2711.
17. Hiraoka M, Nitta N, Nagai M, Shimokado K, Yoshida M. 2004. MCP-1- induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway. Life Sci 75:1333-1341.
18. Kawakami A, Aikawa M, Nitta N, Yoshida M, Libby P, Sacks FM. 2007. Apolipoprotein CIII-induced. THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alphamediated nuclear factor-kappaB activation. Arterioscler Thromb Vasc Biol 27:219-225.
19. Liang J, Liu E, Yu Y, Kitajima S, Koike T, Jin Y, Morimoto M, Hatakeyama K, Asada Y, Watanabe T, Sasaguri Y, Watanabe S, Fan J. 2006. Macrophage metalloelastase accelerates the progression of atherosclerosis in transgenic rabbits. Circulation 113:1993-2001.
20. Liehn EA, Zernecke A, Postea O, Weber C. Chemokines: Inflammatory mediators of atherosclerosis. Arch Physiol Biochem 112:229-238.
21. Lin FJ, Tsai MJ, Tsai SY. 2007. Artery and vein formation: A tug of war between different forces. EMBO Rep 8:920-924.
22. Mazzolai L, Hayoz D. 2006. The renin-Angiotensin system and atherosclerosis. Curr Hypertens Rep 8:47-53.
23. Minami T, Miura M, Aird WC, Kodama T. 2006. Thrombin-induced autoinhibitory factor, Down syndrome critical region-1, attenuates NFAT-dependent vascular cell adhesion molecule-1 expression and inflammation in the endothelium. J Biol Chem 281:20503-20520.
24. Myers SA, Wang SC, Muscat GE. 2006. The chicken ovalbumin upstream promoter-transcription factors modulate genes and pathways involved in skeletal muscle cell metabolism. J Biol Chem 281:24149-24160.
25. Nakano D, Hayashi T, Tazawa N, Yamashita C, Inamoto S, Okuda N, Mori T, Sohmiya K, Kitaura Y, Okada Y, Matsumura Y. 2005. Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-knockout mice. Hypertens Res 28:837-845.
26. Polikandriotis JA, Mazzella LJ, Rupnow HL, Hart CM. 2005. Peroxisome proliferator-Activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-Activated receptor gamma-dependent mechanisms. Arterioscler Thromb Vasc Biol 25: 1810-1816.
27. Simanonok JP. 1996. Non-ischemic hypoxia of the arterial wall is a primary cause of atherosclerosis. Med Hypotheses 46:155-161.
28. Sluimer JC, Daemen MJ. 2009. Novel concepts in atherogenesis: Angiogenesis and hypoxia in atherosclerosis. J Pathol 218:7-29.
29. Swift MR, Weinstein BM. 2009. Arterial-venous specification during development. Circ Res 104:576-588.
30. Tian R. 2003. Transcriptional regulation of energy substrate metabolism in normal and hypertrophied heart. Curr Hypertens Rep 5:454-458.
31. Torres-Vazquez J, Kamei M, Weinstein BM. 2003. Molecular distinction between arteries and veins. Cell Tissue Res 314:43-59.
32. Yanai K, Hirota K, Taniguchi-Yanai K, Shigematsu Y, Shimamoto Y, Saito T, Chowdhury S, Takiguchi M, Arakawa M, Nibu Y, Sugiyama F, Yagami K, Fukamizu A. 1999. Regulated expression of human angiotensinogen gene by hepatocyte nuclear factor 4 and chicken ovalbumin upstream promotertranscription factor. J Biol Chem 274:34605-34612.
33. You LR, Lin FJ, Lee CT, DeMayo FJ, Tsai MJ, Tsai SY. 2005. Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435:98-104.
34. Zhang P, Bennoun M, Gogard C, Bossard P, Leclerc I, Kahn A, Vasseur-Cognet M. 2002. Expression of COUP-TFII in metabolic tissues during development. Mech Dev 119:109-114.
35. Zhang H, Sun A, Shen Y, Jia J, Wang S, Wang K, Ge J. 2004. Artery interposed to vein did not develop atherosclerosis and underwent atrophic remodeling in cholesterol-fed rabbits. Atherosclerosis 177:37-41.